Vitamin D supplementation: Why? How? For whom? And with what?;Supplémentation en vitamine D : Pourquoi ? Comment ? Qui ? Et avec quoi ?

NPG Neurologie - Psychiatrie - Geriatrie

Volumn 13, Issue 74, 2013, Pages 63-70

  Lang, P O ^a,b  

^a CLINIQUE DE GENOLIER   (Switzerland)

^b CRANFIELD UNIVERSITY   (United Kingdom)

Author keywords

25(OH)D; Calcitriol; Chol calcif rol; Cholecalciferol; Suppl mentation; Supplementation; Vitamin D; Vitamine D

Indexed keywords

EID: 84875637911     PISSN: 16274830     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npg.2012.11.002     Document Type: Review

References (69)

1. Holick M.F. Sunlight, UV-radiation, vitamin D and skin cancer: how much sunlight do we need?. Adv Exp Med Biol 2008, 624:1-15.
2. Wikvall K. Cytochrome P450 enzymes in the bioactivation of vitamin D to its hormonal form (review). Int J Mol Med 2001, 7:201-209.
3. Hewison M. An update on vitamin D and human immunity. Clin Endocrinol 2012, 76:315-325.
4. Lang P.O., Samaras N., Samaras D., Aspinall R. How important is Vitamin D in preventing infections?. Intern Osteoporos 2012, 10.1007/s00198-012-2204-6.
5. Holick M.F. Vitamin D: extraskeletal health. Rheum Dis Clin North Am 2012, 38:141-160.
6. Ross A.C., Manson J.E., Abrams S.A., et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the institute of medicine: what clinicians need to know. J Clin Endocrinol Metab 2011, 96:53-58.
7. Dawson-Hughes B., Mithal A., Bonjour J.P., et al. IOF position statement: vitamin D recommendations for older adults. Osteoporos Int 2010, 21:1151-1154.
8. Holick M.F., Binkley N.C., Bischoff-Ferrari H.A., et al. Evaluation, treatment and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2011, 96:1911-1930.
9. Lang P.O., Samaras D. Aging adults and seasonal influenza: does the vitamin D status (h)arm the body?. J Aging Res 2012, 806198. Article ID 806198, doi: 806110.801155/802012/806198.
10. Chapuy M.C., Preziosi P., Maamer M., et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 1997, 7:439-443.
11. Trivalle C., Giot J.L., Lefebvre-Chapiro S., et al. Le déficit en Vitamine D, toujours un problème fréquent en gériatrie. Presse Med 2004, 33:392.
12. Slomski A. IOM endorses vitamin D, calcium only for bone health, dispels deficiency claims. JAMA 2011, 305:453-454. 456.
13. Reid I.R., Avenell A. Evidence-based policy on dietary calcium and vitamin D. J Bone Miner Res 2011, 26:452-454.
14. Hollis B.W. Short-term and long-term consequences and concerns regarding valid assessment of vitamin D deficiency: comparison of recent food supplementation and clinical guidance reports. Curr Opin Clin Nutr Metab Care 2011, 14:598-604.
15. Heaney R.P., Holick M.F. Why the IOM recommendations for vitamin D are deficient. J Bone Miner Res 2011, 26:455-457.
16. Grant W.B. The Institute of Medicine did not find the vitamin D-cancer link because it ignored UV-B dose studies. Public Health Nutr 2011, 14:745-746.
17. Grant W.B., Boucher B.J. Requirements for Vitamin D across the life span. Biol Res Nurs 2011, 13:120-133.
18. Biesalski H.K. Vitamin D recommendations - beyond deficiency. Ann Nutr metab 2011, 59:10-16.
19. Khoo L.A., Chai L., Koenen H., et al. Translating the role of vitamin D3 in infectious diseases. Crit Rev Microbiol 2012, 38:122-135.
20. Bischoff-Ferrari H.A., Keller U., Burckhardt P., et al. Recommandations de la commission fédérale de l'alimentation concernant l'apport de vitamine D. Forum Med Suisse 2012, 12:775-778.
21. Forman J.P., Giovannucci E., Holmes M.D., et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007, 49:1063-1069.
22. Forman J.P., Williams J.S., Fisher N.D. Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans. Hypertension 2010, 55:1283-1288.
23. Pfeifer M., Begerow B., Minne H.W., et al. Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab 2001, 86:1633-1637.
24. Wu S.H., Ho S.C., Zhong L. Effects of vitamin D supplementation on blood pressure. South Med J 2010, 103:729-737.
25. Bischoff-Ferrari H.A., Dawson-Hughes B., Stöcklin E., et al. Oral supplementation with 25(OH)D(3) versus vitamin D(3): effects on 25(OH)D levels, lower extremity function, blood pressure and markers of innate immunity. J Bone Miner Res 2012, 27:160-169.
26. Gorham E.D., Garland C.F., Garland F.C., et al. Optimal vitamin D status for colorectal cancer prevention: a quantitative meta-analysis. Am J Prev Med 2007, 32:210-216.
27. Wei M.Y., Garland C.F., Gorham E.D., Mohr S.B., Giovannucci E. Vitamin D and prevention of colorectal adenoma: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2008, 17:2958-2969.
28. Garland C.F., Gorham E.D., Mohr S.B., et al. Vitamin D and prevention of breast cancer: pooled analysis. J Steroid Biochem Mol Biol 2007, 103:708-711.
29. Chen P., Hu P., Xie D., et al. Meta-analysis of vitamin D, calcium and the prevention of breast cancer. Breast Cancer Res Treat 2010, 121:469-477.
30. Liu P.T., Stenger S., Li H., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311:1770-1773.
31. Avenell A., Cook J.A., Maclennan G.S., Macpherson G.C. Vitamin D supplementation to prevent infections: a sub-study of a randomised placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438). Age Ageing 2007, 36:574-577.
32. Li-Ng M., Aloia J.F., Pollack S., et al. A randomized controlled trial of vitamin D3 supplementation for the prevention of symptomatic upper respiratory tract infections. Epidemiol Infect 2009, 137:1396-1404.
33. Aloia J.F., Li-Ng M. Re: epidemic influenza and vitamin D [with author reply]. Epidemiol Infect 2007, 135:1095-1096. Author reply 1097-1098.
34. Martineau A.R., Leandro A.C., Anderson S.T., et al. Association between Gc genotype and susceptibility to TB is dependent on vitamin D status. Eur Respir J 2009, 35:1106-1112.
35. Kawaura A. Inhibitory effect of long-term 1alpha-hydroxyvitamin D3 administration on Helicobacter pylori infection. J Clin Biochem Nutr 2006, 38:103-106.
36. Munger K.L., Zhang S.M., O'Reilly E., et al. Vitamin D intake and incidence of multiple sclerosis. Neurology 2004, 62:60-65.
37. Chiu K.C., Chu A., Go V.L., Saad M.F. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004, 79:820-825.
38. Borissova A.M., Tankova T., Kirilov G., Dakovska L., Kovacheva R. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract 2003, 57:258-261.
39. Visser M., Deeg D.J., Puts M.T., Seidell J.C., Lips P. Low serum concentrations of 25-hydroxyvitamin D in older persons and the risk of nursing home admission. Am J Clin Nutr 2006, 84:616-622.
40. Dobnig H., Pilz S., Scharnagl H., et al. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med 2008, 168:1340-1349.
41. Ginde A.A., Scragg R., Schwartz R.S., Camargo C.A. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J Am Geriatr Soc 2009, 57:1595-1603.
42. Semba R.D., Houston D.K., Bandinelli S., et al. Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults. Eur J Clin Nutr 2010, 64:203-209.
43. Melamed M.L., Michos E.D., Post W., Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008, 168:1629-1637.
44. Zittermann A., Schleithoff S.S., Frisch S., et al. Circulating calcitriol concentrations and total mortality. Clin Chem 2009, 55:1163-1170.
45. Michaëlsson K., Baron J.A., Snellman G., et al. Plasma vitamin D and mortality in older men: a community-based prospective cohort study. Am J Clin Nutr 2010, 92:841-848.
46. Autier P., Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 2007, 167:1730-1737.
47. Ginde A.A., Mansbach J.M., Camargo C.A. Association between serum 25-hydroxyvitamin D and upper respiratory tract infection in the third national Health and Nutrition Examination survey. Arch Intern Med 2009, 169:384-390.
48. Nnoaham K.E., Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol 2008, 37:113-119.
49. Lang P.O., Samaras D., Samaras N. Does Vitamin D deficiency contribute to further impinge the state of susceptibility to infections of aging and aged adults?. Eur Geriatr Med 2012, 10.1016/j.eurger.2012.11.003.
50. Theiler R., Stähelin H.B., Tyndall A., et al. Calcidiol, calcitriol and parathyroid hormone serum concentrations in institutionalized and ambulatory elderly in Switzerland. Int J Vitam Nutr Res 1999, 69:96-105.
51. Binkley N., Novotny R., Krueger D., et al. Low vitamin D status despite abundant sun exposure. J Clin Endocrinol Metab 2007, 92:2130-2135.
52. Guinot C., Ezzedine K., Mauger E., et al. Phototype, vitamin D status and bone mineral density among women at risk of osteoporosis. Rev Med Interne 2006, 27:369-374.
53. Vernay M., Sponga M., Salanave B., et al. Statut en vitamine D de la population adulte en France - l'étude nationale nutrition santé. BHE 2012, 16-17:189-194.
54. Lips P., Chapuy M.C., Dawson-Hughes B., et al. An international comparison of serum 25-hydroxyvitamin D measurements. Osteoporos Int 1999, 9:394-397.
55. Hamilton B. Vitamin D and human skeletal muscle. Scand J Med Sci Sports 2010, 20:182-190.
56. Binkley N., Kreuger K., Cowgill C., et al. Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. J Clin Endocrinol Metab 2004, 89:3152-3157.
57. Cashman K.D., Wallace J.M., Horigan G., et al. Estimation of the dietary requirement for vitamin D in free-living adults ≥ 64 y of age. Am J Clin Nutr 2009, 89:1366-1374.
58. MacLaughlin J., Holick M.F. Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest 1985, 76:1536-1538.
59. Rosen C.J. Vitamin D insufficiency. N Engl J Med 2011, 364:248-254.
60. Bischoff-Ferrari H.A., Dawson-Hughes B., Staehelin H.B., Orav J.E., et al. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 2009, 339:b3692. doi: 3610.1136/bmj.b3692.
61. Bischoff-Ferrari H.A., Willett W.C., Wong J.B., et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 2009, 169:551-561.
62. Bischoff-Ferrari H.A., Willett W.C., Orav E.J., et al. A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med 2012, 367:40-49.
63. Diffey B. A behavioral model for estimating population exposure to solar ultraviolet radiation. Photochem Photobiol 2008, 84:371-375.
64. Engelsen O. The relationship between ultraviolet radiation exposure and vitamin D status. Nutrients 2010, 2:482-495.
65. Engelsen O., Brustad M., Aksnes L., Lund E. Daily duration of vitamin D synthesis in human skin with relation to latitude, total ozone, altitude, ground cover, aerosols and cloud thickness. Photochem Photobiol 2005, 81:1287-1290.
66. Chel V., Wijnhoven H.A., Smit J.H., Ooms M., Lips P. Efficacy of different doses and time intervals of oral vitamin D supplementation with or without calcium in elderly nursing home residents. Osteoporos Int 2008, 19:663-671.
67. Smith H., Anderson F., Raphael H., et al. Effect of annual intramuscular vitamin D on fracture risk in elderly men and women - a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology (Oxford) 2007, 46:1852-1857.
68. Sanders K.M., Stuart A.L., Williamson E.J., et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 2010, 303:1815-1822.
69. Trivedi D.P., Doll R., Khaw K.T. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double-blind controlled trial. BMJ 2003, 326:469.